Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide

Ricardo A Maselli, John D. Henderson, Jarae Ng, David Follette, Gregory Graves, Barry W. Wilson

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Introduction: Pretreatment with pyridostigmine bromide (PB) of human intercostal muscle fibers exposed to the irreversible acetylcholinesterase (AChE) inhibitor soman was investigated. Methods: Muscles were pretreated with 3 × 10-6 M PB or saline for 20 minutes, then exposed to 10 -7 M soman for 10 minutes. Results: AChE of muscles treated with soman alone was inhibited >95%. In contrast, PB pretreatment of soman-exposed bundles protected 20% of AChE activity. AChE of bundles exposed to PB alone recovered after 4 hours, but bundles exposed to both PB and soman did not. Soman-induced reduction of resting membrane potentials and increment of amplitudes and decay times of miniature endplate potentials (MEPPs) were partially corrected by PB pretreatment. Conclusions: In vitro pretreatment of human muscles with PB protected up to 20% of muscle AChE and ameliorated some deleterious effects on endplate physiology induced by soman.

Original languageEnglish (US)
Pages (from-to)591-595
Number of pages5
JournalMuscle and Nerve
Volume43
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Pyridostigmine Bromide
Soman
Acetylcholinesterase
Muscles
Intercostal Muscles
Cholinesterase Inhibitors
Membrane Potentials

Keywords

  • AChE
  • Human muscle
  • MEPPs
  • Pyridostigmine bromide
  • Soman

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)
  • Physiology

Cite this

Maselli, R. A., Henderson, J. D., Ng, J., Follette, D., Graves, G., & Wilson, B. W. (2011). Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide. Muscle and Nerve, 43(4), 591-595. https://doi.org/10.1002/mus.21922

Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide. / Maselli, Ricardo A; Henderson, John D.; Ng, Jarae; Follette, David; Graves, Gregory; Wilson, Barry W.

In: Muscle and Nerve, Vol. 43, No. 4, 04.2011, p. 591-595.

Research output: Contribution to journalArticle

Maselli, RA, Henderson, JD, Ng, J, Follette, D, Graves, G & Wilson, BW 2011, 'Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide', Muscle and Nerve, vol. 43, no. 4, pp. 591-595. https://doi.org/10.1002/mus.21922
Maselli, Ricardo A ; Henderson, John D. ; Ng, Jarae ; Follette, David ; Graves, Gregory ; Wilson, Barry W. / Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide. In: Muscle and Nerve. 2011 ; Vol. 43, No. 4. pp. 591-595.
@article{71e590d29b6e4ecaa38c3d499d633cd0,
title = "Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide",
abstract = "Introduction: Pretreatment with pyridostigmine bromide (PB) of human intercostal muscle fibers exposed to the irreversible acetylcholinesterase (AChE) inhibitor soman was investigated. Methods: Muscles were pretreated with 3 × 10-6 M PB or saline for 20 minutes, then exposed to 10 -7 M soman for 10 minutes. Results: AChE of muscles treated with soman alone was inhibited >95{\%}. In contrast, PB pretreatment of soman-exposed bundles protected 20{\%} of AChE activity. AChE of bundles exposed to PB alone recovered after 4 hours, but bundles exposed to both PB and soman did not. Soman-induced reduction of resting membrane potentials and increment of amplitudes and decay times of miniature endplate potentials (MEPPs) were partially corrected by PB pretreatment. Conclusions: In vitro pretreatment of human muscles with PB protected up to 20{\%} of muscle AChE and ameliorated some deleterious effects on endplate physiology induced by soman.",
keywords = "AChE, Human muscle, MEPPs, Pyridostigmine bromide, Soman",
author = "Maselli, {Ricardo A} and Henderson, {John D.} and Jarae Ng and David Follette and Gregory Graves and Wilson, {Barry W.}",
year = "2011",
month = "4",
doi = "10.1002/mus.21922",
language = "English (US)",
volume = "43",
pages = "591--595",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide

AU - Maselli, Ricardo A

AU - Henderson, John D.

AU - Ng, Jarae

AU - Follette, David

AU - Graves, Gregory

AU - Wilson, Barry W.

PY - 2011/4

Y1 - 2011/4

N2 - Introduction: Pretreatment with pyridostigmine bromide (PB) of human intercostal muscle fibers exposed to the irreversible acetylcholinesterase (AChE) inhibitor soman was investigated. Methods: Muscles were pretreated with 3 × 10-6 M PB or saline for 20 minutes, then exposed to 10 -7 M soman for 10 minutes. Results: AChE of muscles treated with soman alone was inhibited >95%. In contrast, PB pretreatment of soman-exposed bundles protected 20% of AChE activity. AChE of bundles exposed to PB alone recovered after 4 hours, but bundles exposed to both PB and soman did not. Soman-induced reduction of resting membrane potentials and increment of amplitudes and decay times of miniature endplate potentials (MEPPs) were partially corrected by PB pretreatment. Conclusions: In vitro pretreatment of human muscles with PB protected up to 20% of muscle AChE and ameliorated some deleterious effects on endplate physiology induced by soman.

AB - Introduction: Pretreatment with pyridostigmine bromide (PB) of human intercostal muscle fibers exposed to the irreversible acetylcholinesterase (AChE) inhibitor soman was investigated. Methods: Muscles were pretreated with 3 × 10-6 M PB or saline for 20 minutes, then exposed to 10 -7 M soman for 10 minutes. Results: AChE of muscles treated with soman alone was inhibited >95%. In contrast, PB pretreatment of soman-exposed bundles protected 20% of AChE activity. AChE of bundles exposed to PB alone recovered after 4 hours, but bundles exposed to both PB and soman did not. Soman-induced reduction of resting membrane potentials and increment of amplitudes and decay times of miniature endplate potentials (MEPPs) were partially corrected by PB pretreatment. Conclusions: In vitro pretreatment of human muscles with PB protected up to 20% of muscle AChE and ameliorated some deleterious effects on endplate physiology induced by soman.

KW - AChE

KW - Human muscle

KW - MEPPs

KW - Pyridostigmine bromide

KW - Soman

UR - http://www.scopus.com/inward/record.url?scp=79953036473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953036473&partnerID=8YFLogxK

U2 - 10.1002/mus.21922

DO - 10.1002/mus.21922

M3 - Article

C2 - 21404290

AN - SCOPUS:79953036473

VL - 43

SP - 591

EP - 595

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 4

ER -